Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
2000 2
2001 1
2003 3
2004 3
2005 4
2006 4
2007 6
2008 5
2009 7
2010 9
2011 6
2012 6
2013 10
2014 12
2015 7
2016 9
2017 9
2018 8
2019 10
2020 7
2021 7
2022 13
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome - An Update.
Takakura W, Pimentel M. Takakura W, et al. Front Psychiatry. 2020 Jul 10;11:664. doi: 10.3389/fpsyt.2020.00664. eCollection 2020. Front Psychiatry. 2020. PMID: 32754068 Free PMC article. Review.
Small intestinal bacterial overgrowth (SIBO) is one manifestation of gut microbiome dysbiosis and is highly prevalent in IBS (Irritable Bowel Syndrome). SIBO can be diagnosed either by a small bowel aspirate culture showing 10(3) colony-forming units ( …
Small intestinal bacterial overgrowth (SIBO) is one manifestation of gut microbiome dysbiosis and is highly prevalent in IBS (Irritable
Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Quaglio AEV, et al. World J Gastroenterol. 2022 Aug 14;28(30):4053-4060. doi: 10.3748/wjg.v28.i30.4053. World J Gastroenterol. 2022. PMID: 36157114 Free PMC article. Review.
Dysbiosis, characterized by an imbalance between the beneficial and opportunistic gut microbiota, is associated with several gastrointestinal disorders, such as irritable bowel syndrome (IBS); inflammatory bowel disease (IBD), represented by ulcerative …
Dysbiosis, characterized by an imbalance between the beneficial and opportunistic gut microbiota, is associated with several gastrointestina …
Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome.
Dogan B, Belcher-Timme HF, Dogan EI, Jiang ZD, DuPont HL, Snyder N, Yang S, Chandler B, Scherl EJ, Simpson KW. Dogan B, et al. FEMS Microbiol Lett. 2018 Nov 1;365(22). doi: 10.1093/femsle/fny249. FEMS Microbiol Lett. 2018. PMID: 30299475
Irritable bowel syndrome (IBS) affects 10%-20% of people. Increased numbers of Escherichia coli (E. coli) correlate with symptoms, and patients respond to antimicrobials targeting E. coli. ...Escherichia coli capable
Irritable bowel syndrome (IBS) affects 10%-20% of people. Increased numbers of Escherichia coli (E. co
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis.
Baumgartner M, Lang M, Holley H, Crepaz D, Hausmann B, Pjevac P, Moser D, Haller F, Hof F, Beer A, Orgler E, Frick A, Khare V, Evstatiev R, Strohmaier S, Primas C, Dolak W, Köcher T, Klavins K, Rath T, Neurath MF, Berry D, Makristathis A, Muttenthaler M, Gasche C. Baumgartner M, et al. Gastroenterology. 2021 Oct;161(4):1245-1256.e20. doi: 10.1053/j.gastro.2021.06.024. Epub 2021 Jun 17. Gastroenterology. 2021. PMID: 34146566 Free PMC article.
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) and inflammatory bowel diseases result in a substantial reduction in quality of life and a considerable socioeconomic impact. ...These yellow-green adherent layers of the ileum and right-sided colon …
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) and inflammatory bowel diseases result in a substantial re …
Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity.
Han L, Zhao L, Zhou Y, Yang C, Xiong T, Lu L, Deng Y, Luo W, Chen Y, Qiu Q, Shang X, Huang L, Mo Z, Huang S, Huang S, Liu Z, Yang W, Zhai L, Ning Z, Lin C, Huang T, Cheng C, Zhong LLD, Li S, Bian Z, Fang X. Han L, et al. ISME J. 2022 Apr;16(4):983-996. doi: 10.1038/s41396-021-01123-5. Epub 2021 Nov 8. ISME J. 2022. PMID: 34750528 Free PMC article.
Irritable bowel syndrome (IBS) is one of the functional gastrointestinal disorders characterized by chronic and/or recurrent symptoms of abdominal pain and irregular defecation. ...We further identified 522 robust associations between differentially abundant
Irritable bowel syndrome (IBS) is one of the functional gastrointestinal disorders characterized by chronic and/or recu
Gut microbial beta-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome.
Edwinson AL, Yang L, Peters S, Hanning N, Jeraldo P, Jagtap P, Simpson JB, Yang TY, Kumar P, Mehta S, Nair A, Breen-Lyles M, Chikkamenahalli L, Graham RP, De Winter B, Patel R, Dasari S, Kashyap P, Griffin T, Chen J, Farrugia G, Redinbo MR, Grover M. Edwinson AL, et al. Nat Microbiol. 2022 May;7(5):680-694. doi: 10.1038/s41564-022-01103-1. Epub 2022 Apr 28. Nat Microbiol. 2022. PMID: 35484230 Free PMC article.
Intestinal proteases mediate digestion and immune signalling, while increased gut proteolytic activity disrupts the intestinal barrier and generates visceral hypersensitivity, which is common in irritable bowel syndrome (IBS). However, the mechanisms controll …
Intestinal proteases mediate digestion and immune signalling, while increased gut proteolytic activity disrupts the intestinal barrier and g …
Rifaximin.
Robertson KD, Nagalli S. Robertson KD, et al. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32966000 Free Books & Documents.
Rifaximin is an antibiotic used to treat irritable bowel syndrome with diarrhea, reduce the risk of overt hepatic encephalopathy recurrence in adults, and treat travelers' diarrhea caused by noninvasive strains of Escherichia coli. ...
Rifaximin is an antibiotic used to treat irritable bowel syndrome with diarrhea, reduce the risk of overt hepatic encep …
Association of enteroaggregative Escherichia coli with irritable bowel syndrome.
Sobieszczańska BM, Osek J, Waśko-Czopnik D, Dworniczek E, Jermakow K. Sobieszczańska BM, et al. Clin Microbiol Infect. 2007 Apr;13(4):404-7. doi: 10.1111/j.1469-0691.2006.01669.x. Clin Microbiol Infect. 2007. PMID: 17359324 Free article.
Increased numbers of faecal Enterobacteriaceae are observed among patients with irritable bowel syndrome. Escherichia coli strains are present in the lower intestine of humans, and may include several potentially pathogenic adhesive pathotypes. …
Increased numbers of faecal Enterobacteriaceae are observed among patients with irritable bowel syndrome. Escherichi
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators.
Barbaro MR, Fuschi D, Cremon C, Carapelle M, Dino P, Marcellini MM, Dothel G, De Ponti F, Stanghellini V, Barbara G. Barbaro MR, et al. Neurogastroenterol Motil. 2018 Jun 28:e13388. doi: 10.1111/nmo.13388. Online ahead of print. Neurogastroenterol Motil. 2018. PMID: 29956419
BACKGROUND: Intestinal permeability is altered in a subgroup of irritable bowel syndrome (IBS) patients and may contribute to symptom development. The aim of this study was to evaluate the in vitro effect of the probiotic Escherichia coli Nissle …
BACKGROUND: Intestinal permeability is altered in a subgroup of irritable bowel syndrome (IBS) patients and may contrib …
Diet and gut microbial associations in irritable bowel syndrome according to disease subtype.
Wang Y, Ma W, Mehta R, Nguyen LH, Song M, Drew DA, Asnicar F, Huttenhower C, Segata N, Wolf J, Spector T, Berry S, Staller K, Chan AT. Wang Y, et al. Gut Microbes. 2023 Dec;15(2):2262130. doi: 10.1080/19490976.2023.2262130. Epub 2023 Oct 2. Gut Microbes. 2023. PMID: 37786251 Free PMC article.
The role of diet and the gut microbiome in the etiopathogenesis of irritable bowel syndrome (IBS) is not fully understood. Therefore, we investigated the interplay between dietary risk factors and gut microbiota in IBS subtypes using a food frequency question …
The role of diet and the gut microbiome in the etiopathogenesis of irritable bowel syndrome (IBS) is not fully understo …
138 results